Loading clinical trials...
Loading clinical trials...
An Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Autoimmune Diseases
Conditions
Interventions
GC012F injection
Start Date
August 18, 2025
Primary Completion Date
March 31, 2027
Completion Date
March 31, 2029
Last Updated
July 18, 2025
NCT07413341
NCT06991114
NCT06792344
NCT06888960
NCT06828042
NCT07085676
Lead Sponsor
Qiong Fu
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions